Prof. Harvinder Popli

Employment

• Delhi Pharmaceutical Science and Research University Director
  2016 - Present

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (24)

• Conjugates of amphotericin B to resolve challenges associated with its delivery
  Expert Opinion on Drug Delivery 2024 DOI: 10.1080/17425247.2024.2308073
  +Save
• Development and optimization of Clitoria teratea synthesized silver nanoparticles and its application to nanogel systems for wound healing
  Drug Development and Industrial Pharmacy 2024 DOI: 10.1080/03639045.2024.2308043
  +Save
• Nanoformulations of amphotericin B to resolve challenges in antifungal therapy
  Nanomedicine 2024 DOI: 10.1080/17435889.2024.2407281
  +Save
• Nanotheranostics for Diagnosis and Treatment of Breast Cancer
  Current Pharmaceutical Design 2023 DOI: 10.2174/1381612829666230329122911
  +Save
• Pathophysiology of Diabetes- Induced Foot Ulcers and Therapy Options
  Biomedical Research, Medicine, and Disease 2023 DOI: 10.1201/9781003220404-23
  +Save
• Patient satisfaction with access, affordability and quality of diabetes care at Mohalla Clinics in Delhi, India
  Frontiers in Public Health 2023 DOI: 10.3389/fpubh.2023.1160408
  +Save
• Stepping into small shoes: Gaining user perspective on appropriate administration devices for paediatric medication in India
  European Journal of Pharmaceutics and Biopharmaceutics 2023 DOI: 10.1016/j.ejpb.2023.09.005
  +Save
• The therapeutic potential of flavonoids in the management of high-fat diet-induced metabolic disorders: Evidence obtained from pre-clinical and clinical studies
  Everything You Need to Know About High-Fat Diets 2023
  +Save
• Design-of-Experiments (DoE)-Assisted Fabrication of Quercetin-Loaded Nanoemulgel and Its Evaluation against Human Skin Cancer Cell Lines
  Pharmaceutics 2022 DOI: 10.3390/pharmaceutics14112517
  +Save
• Nanoemulsions as effective carriers for targeting brain tumors
  Nanocarriers for Drug-Targeting Brain Tumors 2022 DOI: 10.1016/B978-0-323-90773-6.00008-7
  +Save